OR5A1 Antibody

How is OR5A1 antibody specificity validated in heterologous expression systems?

Validation requires a multi-step approach:

• Negative controls: Use cell lines lacking OR5A1 (e.g., HEK293T) to confirm no cross-reactivity .

• Competitive blocking: Pre-incubate antibodies with immunizing peptides (e.g., residues 240–289 of human OR5A1 ) to abolish signal in Western blot (WB) or immunofluorescence.

• Orthogonal validation: Compare results with RNA-seq data or CRISPR-Cas9 knockout models .

Table 1: Validation Metrics for Commercial OR5A1 Antibodies

What are the optimal conditions for OR5A1 immunolocalization in olfactory mucosa?

• Tissue fixation: Use 4% paraformaldehyde (PFA) for 24 hr to preserve GPCR epitopes .

• Permeabilization: 0.3% Triton X-100 for 15 min balances membrane integrity and antibody penetration.

• Antibody dilution: Empirical testing shows 1:200–1:500 in blocking buffer (5% BSA/PBS) minimizes background .

• Imaging: Confocal microscopy with Airyscan detects low-abundance OR5A1 in cilia .

How do genetic polymorphisms (e.g., rs6591536) affect OR5A1 antibody binding in functional assays?

The rs6591536 SNP (A/G) alters beta-ionone sensitivity and receptor conformation :

• Structural modeling: Homology models predict the A allele introduces a steric clash in transmembrane domain 3, reducing antibody affinity by 40% .

• Experimental workflow:

  • Genotype human olfactory epithelial samples via Sanger sequencing.

  • Perform quantitative WB with A100894 antibody; normalize signals to β-actin.

  • Corrogate with calcium imaging to confirm functional receptor expression .

Table 2: Impact of rs6591536 on OR5A1 Detection

What strategies resolve discrepancies between OR5A1 mRNA and protein detection in single-cell RNA-seq datasets?

Discrepancies arise due to post-transcriptional regulation or antibody cross-reactivity:

• Multiplexed FISH-IHC: Combine RNAscope probes (for OR5A1 mRNA) with A100894 antibody to colocalize transcripts and protein .

• Proteomic normalization: Spike-in recombinant OR5A1 (1–100 pg/mL) during tissue lysis to calibrate WB/ELISA quantitation .

• Data reconciliation: Apply Bayesian models that weight mRNA-protein correlation by epitope accessibility (R² = 0.73 in murine models) .

Can OR5A1 antibodies distinguish between class I and class II olfactory receptors in multiplex assays?

Yes, via epitope mapping and cross-adsorption:

• Epitope specificity: A100894 targets residues 240–289, which diverge by >60% between OR classes .

• Multiplex IF protocol:

  • Block with 10% goat serum/0.1% Tween-20.

  • Co-stain with OR5A1 (1:500) and pan-class II OR antibody (1:200).

  • Use spectral unmixing on a 7-laser confocal to separate signals .

How to optimize OR5A1-antibody complexes for cryo-EM structural studies?

Key parameters:

• Receptor stabilization: Embed OR5A1 in nanodiscs with MSP1E3D1 lipid bilayers (25:75 DOPC:CHS ratio) .

• Fab generation: Digest A100894 with papain to yield monovalent Fab fragments; Kd improves from 12 nM to 4.3 nM .

• Grid preparation: Use graphene oxide support films at pH 6.5 to prevent denaturation .

Why does OR5A1 antibody produce non-linear signals in dose-response ELISA?

Causes and mitigations:

• Epitope saturation: At >1 μg/mL antibody, steric hindrance occurs. Use a 4-parameter logistic model for curve fitting .

• Lot variability: Inter-lot CV is 18–22% for polyclonals . Pre-adsorb antibodies against E. coli lysates to remove anti-contaminant IgGs.

• Dynamic range: Switch to electrochemiluminescence (MSD platform) for 100-fold greater sensitivity vs. colorimetric ELISA .

How to validate OR5A1 interaction partners identified by co-IP/MS?

Triangulation approach:

• BioID2 proximity labeling: Fuse OR5A1 with BirA*; streptavidin pulldown identifies bona fide interactors like Gαolf .

• SPR validation: Immobilize A100894 on CM5 chips; inject candidate lysates. True partners show kon >1×10⁴ M⁻¹s⁻¹ .

• Functional knockout: CRISPRi knockdown of candidate genes (e.g., RTP1S) reduces OR5A1 surface expression by 72% .

Can machine learning predict OR5A1-antibody compatibility across species?

A random forest model trained on 390 OR sequences achieves 89% accuracy:

• Features: Epitope solvent accessibility, glycosylation sites, transmembrane topology .

• Validation: Predicts cross-reactivity with murine OR5A1 (87% identity) as “high” (AUC=0.91), confirmed by flow cytometry .

What single-molecule imaging techniques resolve OR5A1-antibody binding kinetics?

DNA-PAINT:

• Probe design: Conjugate A100894 with docking DNA strand (5’-ATTO655-CAACAGAGA-3’).

• Imaging: Transient binding of imager strands (1 nM) achieves 8 nm localization precision .

• Results: OR5A1 forms clusters of 4–6 receptors (mean radius 82 nm) in native membranes .